Download curriculum vitae

CURRICULUM VITAE
PEDRO F. ESCOBAR, M.D.
CLEVELAND CLINIC
9500 Euclid Ave.
Cleveland, OH 44195
PERSONAL DATA:
Place and Date of Birth:
Caguas, P.R., USA
September 7, 1971
Home Address:
1390 Slate Court
Cleveland Heights, OH 44118
Work Address:
Cleveland Clinic
Desk A81, 9500 Euclid Ave.
Cleveland, OH 44195
Tel 216-445-8486
Fax 216-444-8551
Email [email protected]
Marital Status:
Married
Wanda I. Lopez
Children: Pedro A. Escobar Lopez
Anamarie Escobar Lopez
EDUCATION AND TRAINING:
Undergraduate Education:
1989-1994 B.S. Biochemistry
Florida Institute of Technology
Melbourne, Florida
Medical Education:
1994-1998 M.D.
University of Puerto Rico
San Juan, P.R., USA
Internship:
1998-1999
University of Puerto Rico
Department of Obstetrics and Gynecology
San Juan, P.R., USA
Residency:
1999-2002
Northwestern University
Department of Obstetrics and Gynecology
Chicago, IL
EDUCATION AND TRAINING - continued
Fellowship:
2002-2003 Research
Cleveland Clinic
Department of Cancer Biology
Cleveland, OH
Fellowship:
2003-2004 Breast Surgery
Cleveland Clinic
Department of General Surgery
Cleveland, OH
Fellowship:
2004-2006 Gynecologic Oncology
Cleveland Clinic
Department of Obstetrics and Gynecology
Cleveland, OH
APPOINTMENT AND POSITIONS
2002-2003
Research Fellow
Cleveland Clinic
Department of Obstetrics and
Gynecology/Cancer Biology
2003-2004
Clinical Fellow
Cleveland Clinic
Department of Surgery
2004-2006
Clinical Fellow
Cleveland Clinic
Department of Obstetrics and Gynecology
2006-2008
Assistant Staff Gynecologic OncologyBreast Surgeon
Florida Gynecologic Oncology
Lee Cancer Center, Lee Memorial Hospital
2008-Present
Staff Cleveland Clinic
OB/GYN and Women’s Institute
Section of Gynecologic Oncology
2009 - Present
Director, Robotic and Minimally Invasive
Surgery/Section of Gynecologic Oncology
OB/GYN and Women’s Institute
2009 – Present
Assistant Professor
Department of Ob-Gyn
Ponce School of Medicine
APPOINTMENT AND POSITIONS – continued
2009 – Present
Physician Advisor
International Leadership Board
Cleveland Clinic
2009 – Present
Advisory Board Member
Center for International Medical Education
Cleveland Clinic
2009 – Present
Assistant Professor of Surgery
Cleveland Clinic Lerner College of
Medicine of Case Western University
2009 – Present
Joint Appointment
Genomic Medicine Institute
Lerner Research Institute
2010 – Present
Director of Minimally Invasive and Robotic
Surgery
OB/GYN and Women’s Health Institute
BOARD CERTIFICATION
December 2005
American Board of Obstetrics and
Gynecology
April 2008
Subspecialty Board Certification
Gynecologic Oncology
Fellow – The American Board of Obstetrics
and Gynecology
Fellow – American College of Surgeons
LICENSURE
State of Ohio (#35-08-1008-E)
State of Illinois (#036-103602)
State of Florida (ME 95829)
Commonwealth of Puerto Rico, USA (016410)
MEDICAL SOCIETY MEMBERSHIP
Society of Surgical Oncology
American Society of Clinical Oncology
MEDICAL SOCIETY MEMBERSHIP - continued
American College of Surgeons
Society of Gynecologic Oncology
American Society of Breast Disease
American College of Obstetrics and Gynecology
Royal Society of Medicine (Fellow)
Advancing Minimally Invasive Gynecology Worldwide
The International Society for Gynecologic Endoscopy
International College of Surgeons – (Fellow)
International Gynecologic Cancer Society
American Congress of Obstetrics and Gynecology
Society of Laparoendoscopic Surgeons
HONORS
Alpha Omega Alpha – 1997
Cum Laude – Florida Institute of Technology – 1994
New Investigator Award Finalist – American Institute of Ultrasound in Medicine – 2001
Resident’s Award – Excellence in Operative Endoscopy, Northwestern University – 2002
American Association for Cancer Research – Minority Scholar in Cancer Research Award - 2003
American Association for Cancer Research – Advances in Breast Cancer Research Travel
Award – 2003
ASCO / AACR / NCI Clinical Cancer Research Workshop – 2003
Best Poster Award – 25th Annual Miami Breast Cancer Conference – 2008
Best Paper Award - Mimimally Invasive Gynecolgic Oncology - AAGL – 2010
INTERNATIONAL RESEARCH
Preventive Oncology International
Optical Imaging / Biopsy – Cervical Cancer Screening
Breast Cancer Surgery / Awareness
Project Site Director – Dominican Republic – 2004
Lifeline Biotechnologies – Visiting surgical instructor in breast surgery
Beijing Third University Hospital, China – 2005
GRANTS – PRINCIPAL INVESTIGATOR
Genomic Stability and DNA Polymerase beta in ovarian and breast cancer.
Research Programs Council, The Cleveland Clinic, RPC#07223, $25,000.
April 22, 2003-April 21, 2004
CLINICAL RESEARCH
Principle Investigator:
ARC 08993
Advanced Laparoscopic and Minimally Invasive Surgery Workshops in Gynecology
(eSirius 0090)
Principle Investigator:
BIBF 1199.15
Multicenter, randomized, double-blind, phase III trial to investigate the efficacy and
safety of BIBF 1120 in combination with standard treatment of Carboplatin and
paclitaxel compared to placebo plus Carboplatin and paclitaxel in patients with advanced
ovarian cancer
Principle Investigator:
PT-301
A non-interventional prospective study of the correlation of the Precision Therapeutics,
Inc. Chemoresponsive assay with progression-free survival in patients with recurrent
epithelial ovarian, peritoneal, or fallopian tube cancer
Co-Investigator:
Gynecologic Oncology Group – 187
Phase II study of Paclitaxel for Ovarian Stromal Tumors as second-line therapy
Co-Investigator:
IRB # 4614
Ganapathi – The use of microarray technology for identifying relevant genes in
chemotherapy resistant ovarian cancer (internal)
Co-Investigator:
Gynecologic Oncology Group – 209
Phase 3 randomized study of Doxorubicin, Paclitaxel, Cisplatin, and G-CSF v.
Carboplatin and Paclitaxel in patients with Stage III, IV, or recurrent endometrial cancer
Co-Investigator:
Gynecologic Oncology Group – 205
A Phase II trial of radiation therapy and weekly Cisplatin chemotherapy for the treatment
of locally-advanced squamous cell carcinoma of the vulva
Co-Investigator:
Gynecologic Oncology Group – 9917
A dose-escalating phase I study with an expanded cohort to assess the feasibility of
intraperitoneal Carboplatin (NSC #214270) and intravenous Paclitaxel (NSC #673089) in
patients with previously untreated epithelial ovarian, primary, peritoneal, or fallopian
tube carcinoma
CLINICAL RESEARCH – continued
Co-Investigator:
Gynecologic Oncology Group – 9916
A phase I trial of intravenous Paclitaxel Carboplatin and Intraperitoneal Paclitaxel or
intravenous Docetaxel, Intraperitoneal Carboplatin and Intraperitoneal Paclitaxel in
patients with optimal Stage III epithelial ovarian carcinoma or primary peritoneal
carcinoma
Co-Investigator:
Gynecologic Oncology Group – 212
A randomized phase III trial of maintenance chemotherapy comparing 12, monthly cycles
of single agent Paclitaxel or Xyotax versus no treatment until documented relapse in
women with advanced ovarian or primary peritoneal cancer achieve a complete clinical
response to primary platinum/taxane chemotherapy
Co-Investigator:
Gynecologic Oncology Group – 210
A molecular staging study of endometrial carcinoma
Co-Investigator:
Gynecologic Oncology Group – 9918
Phase I trial of tailored radiation therapy with concomitant Cetuximab and Cisplatin in
the treatment of patients with cervical cancer
Co-Investigator:
Gynecologic Oncology Group – 218
A phase III trial of Carboplatin and Paclitaxel plus placebo versus Carboplatin and
Paclitaxel plus concurrent Bevacizumab followed by placebo, versus Carboplatin and
Paclitaxel plus concurrent and extended Bevacizumab in women with newly diagnosed,
previously untreated, Stage III or IV, epithelial ovarian or primary peritoneal cancer
Co-Investigator:
Gynecologic Oncology Group – 222
Prospective evaluation of pelvic exenteration in patient with recurrent cervical cancer
Co-Investigator:
Gynecologic Oncology Group – 219
A phase III randomized trial of weekly Cisplatin and radiation versus Cisplatin and
Tirapazamine and radiation in Stage IB2, IIA, IIB, IIIB and IVA cervical cancer limited
to the pelvis
CLINICAL RESEARCH – continued
Co-Investigator:
AVF4119s
A phase II trial of a vascular endothelial growth factor (VEGF) monoclonal antibody,
Avastin, in combination with cytotoxic chemotherapy Carboplatin and Paclitaxel for
recurrent/advanced endometrial cancer
Co-Investigator
Fran1807-CC307
Fran-Detection of early stage ovarian cancer: a clinical protocol to evaluate
plasmalogens to detect the presence of early stage ovarian cancer in women scheduled for
surgery with a pelvic mass or a suspected ovarian malignancy
Co-Investigator:
Gene2807-CC356
A phase II, multicenter, randomized, blinded, placebo-controlled trial of Carboplatin and
Gemcitabine plus Bevacizumab in patients with Platinum-sensitive recurrent ovary,
primary peritoneal, or fallopian tube carcinoma
Co-Investigator:
MEPL 1808-CC521
Multi-center, randomized, double-blind, phase III efficacy study comparing Phenoxodiol
in combination with Carboplatin versus Carboplatin with placebo in patients with
Platinum resistant or refractory late-stage epithelial ovarian, fallopian or primary
peritoneal cancer following at least second line Platinum therapy
INVITED LECTURES
Cleveland Clinic
Grand Rounds
Department of Obstetrics and Gynecology
2003
Mastology Society of Dominican Republic
“Recent Advances in Breast Cancer Surgery”
2004
Lee Memorial Hospital
Fort Myers, Florida
Cancer Center
2004
Caribe Gynecology 1st Annual Meeting
Ponce, Puerto Rico
“Minimally Invasive Surgery in Gynecology” 2004
INVITED LECTURES - continued
Royal Society of Medicine Section of Oncology
London, U.K.
Breast Cancer
“Sylvia-Lawler Prize Lecture”
2005
Florida Society of Gynecologic Oncologist
“Breast Endoscopy”
Annual Meeting 2005
Caribe Gynecology 2nd Annual Meeting
Ponce, Puerto Rico
“Breast Disease”
2005
Lee Memorial Hospital
Fort Myers, Florida
Cancer Center 2005
Third-Beijing University Hospital
China
Grand Rounds
“Breast Endoscopy”
2005
The Cleveland Clinic
Updates in Gynecologic Endoscopy, Instructor
2003-2006
Society of Gynecologic Oncology
Breast Course Annual Meeting
2007
University of South Dakota
School of Medicine
Grand Rounds
“Breast Endoscopy”
2007
Caribe Gynecology 4th Annual Meeting
Ponce, Puerto Rico
“Robotic Surgery in Gynecology”
2007
INVITED LECTURES - continued
Florida Obstetrics and Gynecology Society Annual Meeting
Naples, Florida
“Breast Lab”
2007
American College of Surgeons – Puerto Rico Chapter 58th Annual Meeting
San Juan, PR, USA
“Robotic and Minimally Invasive Surgery in Gynecologic Oncology
February 2008
Caribe Gynecology 5th Annual Meeting
Ponce, Puerto Rico
“Breast Cancer: Risk and New Alternatives”; “Cervical Cancer Updates: New
Modalities and Alternatives for Management”
August 2008
Hillcrest Hospital
Women’s Health and Education
Breast, Cervical and Ovarian Carcinoma
October 22, 2008
Hospital Episcopal San Lucas
Surgical Rounds and Teaching Ob/Gyn Department
Ponce, Puerto Rico
October 10, 2008
Hospital Episcopal San Lucas
Surgical Rounds and Teaching Ob/Gyn Department
Ponce, Puerto Rico
December 19-20, 2008
Cleveland Society of Ob-Gyn
Cleveland, Ohio
“An Update on the Management of Molar Pregnancy
and Gestational Trophoblastic Disease”
January 21, 2009
Precision Therapeutics, Inc.
San Juan, Puerto Rico
“New Trends in Managing Cancer”
February 12, 2009
INVITED LECTURES - continued
Grand Rounds
Hillcrest Hospital
“Update on Robotic and Minimally Invasive Surgery for Gynecology”
March 19, 2009
Advances in Gynecologic Surgery
Cleveland Clinic
“Single-Port Laparoscopy and NOTES
May 14, 2009
Single-Port Laparoscopy, NOTES, and Endoluminal Surgery
Cleveland Clinic
“Robotic Single-Port Lymphadenectomy”
May 29, 2009
Healthwise Connection Program
Mayfield Community Center
“Advantages of Robotic Surgery in Gynecology”
June 10, 2009
BIT Life Sciences’ 2nd World Cancer Congress
Beijing, China
“Tissue-culture Based Chemosensitivity Assays in the Management of Patients with
Ovarian Cancer”
June 24, 2009
Hospital Episcopal San Lucas
Surgical Rounds and Teaching Ob/Gyn Department
Ponce, Puerto Rico
June 30, 2009
Caribe Gynecology 6th Annual Meeting
Ponce, Puerto Rico
“Breast Cancer: Risk and New Alternatives”; “Cervical Cancer Updates: New
Modalities and Alternatives for Management”
August 6, 2009
International Gynecology Invitational Symposium
Cleveland Clinic
“Single Port Laparoscopy”; “The Difficult Abdominal Hysterectomy”
August 24-26, 2009
INVITED LECTURES - continued
Loyola University School of Medicine
Chicago, Illinois
“Single Port Laparoscopy (LESS) in Gynecologic Oncology
September 30, 2009
American College of Obstetricians and Gynecologists Minneapolis
Minneapolis, MN
“Single Incision Laparoscopic Surgery (SILS)
“Breast Disease: What’s Important and Why?”
November 14, 2009
American Association of Gynecologic Laparoscopists Symposium
Orlando, Florida
“Laparoendoscopic Single Site Surgery (LESS) in Gynecologic Oncology
November 15-19, 2009
Integrative and Translational Genomic Medicine Seminar Series
Cleveland Clinic
“Single-Port Laparoscopy for Prophylactic Surgery”
November 20, 2009
Minimally Invasive Gynecology and Ambulatory Gynecology Cleveland Clinic Florida
Fort Lauderdale, Florida
“BSO & Hysterectomy: An oncologist’s perspective, conservative management of
gynecologic malignancies.”
January 22-25, 2010
60th Annual Meeting – American College of Surgeons Puerto Rico Chapter
San Juan, Puerto Rico
“Single Port Laparoscopy in Gynecologic Cancer Surgery”
February 25-27, 2010
Pan American Robotic Oncology Symposium
Houston, Texas
“Robotic-Assisted Single Site Surgery in Gynecologic Oncology”
February 27, 2010
Cleveland Clinic Center for Surgical Innovation
Cleveland, Ohio
Single Port Laparoscopy in Gynecology
Conference Director
“Single Port Applications in Gynecologic Oncology”
“Single Port Robotic Surgery and Future Trends”
March 4-5, 2010
INVITED LECTURES - continued
SGO 2010 Annual Meeting on Women’s Cancer
San Francisco, California
Montz Symposium: Future of Minimally Invasive Surgery in Gynecologic Oncology
March 2010
Cleveland Clinic
Grand Rounds
“Single Port Laparoscopy”
March 24, 2010
St. Vincent Health Center
Erie, PA
Grand Rounds
“Robotic Surgery in Gynecology”
April 30, 2010
Advances in Gynecologic Surgery
Single-Port Laparoscopy, NOTES, and Endoluminal Surgery
Cleveland Clinic
May 14-15, 2010
National Congress Ob-Gyn
Cali, Columbia
Laparoendoscopic Single Site Surgery
May 18-21, 2010
International Society for Gynecologic Endoscopy
Sydney, Australia
Single Port Laparoscopy
May 26-29, 2010
Advances in Minimally Invasive Surgery
Gynecologic Robotic Surgery
The Hilton Beachwood
July 20, 2010
10ma Convención Científica Facultad Médica HIMA San Pablo Caguas
Ponce, PR
Single Port Laparoscopy and Robotic Surgery
September 17-18, 2010
INVITED LECTURES - continued
Spotlight on Cleveland Clinic
“Advances in Minimally Invasive Surgery in Gynecologic Oncology from Research to
Clinical Practice”
October 5, 2010
AAGL Global Congress of Minimally Invasive Gynecology
Las Vegas, Nevada
“Robotic Single-Site Surgery: New Horizons with VESPA Technology”
“Getting Started with Single-Port Laparoscopy – Basic Procedures”
“Potential Applications in Gynecologic Oncology”
“Single Port Surgery: Present and Future”
November 8, 2010
2nd International Gynecology Invitational Symposium on Minimally Invasive Surgery
Cleveland Clinic
Conference Director
“Single Port Robotics, Research and Clinical Practice”
December 1-3, 2010
7th Annual Minimal Access Gynecology
Ft. Lauderdale, Florida
“Single-Port Laparoscopy from Research to Clinical Practice”
“Managing the Complex Adnexal Mass”
January 21-24, 2011
Trends and Technologies in Gynecologic Surgery and Oncology
Gate Institute, Holy Cross Hospital
Cambridge, Maryland
“Single Port Access Surgery in Gynecology”
“Laparoscopic Evaluation of Pelvic Mass”
April 2-3, 2011
MINIMALLY INVASIVE SURGICAL LABS/COURSES
Ohio State University-Covidien
Columbus, Ohio
August 22, 2009
University of Cincinnati-Covidien
September 11, 2009
Pavia Hospital-Olympus
San Juan, Puerto Rico
October 9, 2009
MINIMALLY INVASIVE SURGICAL LABS/COURSES – continued
Universidad Autónoma de Centroamérica-Costa Rica-Olympus
October 19, 2009
Greater Baltimore Medical Center and Johns Hopkins
Baltimore, Maryland
Multispecialty Single Port Laparoscopic Surgery Symposium
April 23, 2010
Cleveland Clinic-Covidien
Cleveland, Ohio
Single Incision Laparoscopic Surgery Course: Hysterectomy and other Gynecologic
Applications
July 17, 2010
Intuitive Surgical
San Francisco, CA
September 9-10, 2010
AAGL Global Congress of Minimally Invasive Gynecology
Las Vegas, Nevada
Innovations in Robotics and Laparoscopy in Oncology
November 8, 2010
Single Port Laparoscopy
November 9, 2010
Sirio Libanes Hospital
Sao Paulo, Brazil
LESS Training
February 17-19, 2011
Hospital HIMA-San Pablo
Caguas, PR
Surgical preceptor for Minimally Invasive Surgery
February 24-26, 2011
SGO 2011 Annual Meeting
Orlando, Florida
Advanced Robotic Surgery for the Gynecologic Oncologist
March 4, 2011
Cleveland Clinic-Covidien
Cleveland, Ohio
Surgical Advancements in Gyn Surgery: Minimally Invasive Hysterectomy Options
March 12, 2011
EDITORIAL BOARDS
Editorial Board (2006-present): International Seminars in Surgical Oncology
Editorial Panel (2006-present): Breast Cancer Reviews
Editorial Board (2008-present): Diagnostic and Therapeutic Endoscopy
Editorial Board (2010-present): “The Open Breast Cancer Journal”
NATIONAL COMMITTEES
Society of Gynecologic Oncology
Candidate Representative – Breast committee
American Society of Breast Disease
ASBD Breast Education Committee
The Susan G. Komen Breast Cancer Foundation
Scientist Reviewer for National Grant Cycle 2006-2007
Scientist Reviewer for National Grant Cycle 2007-2008
Department of Defense, United States
Grant Reviewer 2009
Journal of Minimally Invasive Gynecology
Ad- hoc Reviewer 2010
International Journal of Gynecology and Obstetrics
Ad- hoc Reviewer 2010
AAGL, Oncology Special Interest Group (SIG)
Board Member 2010
PEER REVIEWED ABSTRACTS
Escobar PF, Cohen L, Fishman D. Three-dimensional power Doppler ultrasound: Does
it improve the detection of ovarian cancer? The Society of Gynecologic Oncologist; 32nd
Annual Meeting, March 2000
Escobar PF, Lurain JF. Multiagent chemotherapy for high-risk gestational trophoblastic
disease. Oral presentation at the XI World Congress on Gestational Trophoblastic
Disease. Santa Fe, New Mexico, USA., October 27-31, 2001.
PEER REVIEWED ABSTRACTS – continued
Escobar PF, Cohen, L, Fishman D. Three-dimensional ultrasound and ovarian cancer.
Oral presentation at the American Institute of Ultrasound in Medicine. 45th Annual
Convention, March 2001.
Fishman DA, Cohen L, Bozorgi K, Singh D, O’Donnell A, Donnely MA, O’Rourke J,
Escobar PF, Lurain J. Ultrasound for detection of early stage epithelial ovarian
carcinoma. 33rd Annual Meeting, Society of Gynecologic Oncologist, March 2001.
Bhattacharyya N, Escobar PF, Banerjee S. A DNA repair gene-potential marker for
ovarian cancer. The 8th World Congress on Advances in Oncology / 5th International
Symposium on Molecular Medicine, October 2003, Crete, Greece.
Escobar PF, Wang L, Bhattacharyya N, Banerjee S. Truncated Forms of DNA
Polymerase in Serous Borderline Ovarian Tumors. Poster Presentation. American
Association for Cancer Research. Annual Meeting – Washington, D.C., 2003.
Escobar PF, Markman M, Rose P, Zanotti K, Webster K, Belinson JL. Phase 2 Trial of
Carboplatin, Paclitaxel and Irinotecan in Ovarian, Fallopian Tube and Primary Peritoneal
Cancers. Oral poster presentation. American Society of Clinical Oncology-Annual
Meeting, Chicago, IL 2003.
Escobar PF, Bhattacharyya N, Grundfest S, Crowe J, Banerjee S. Expression of
Ubiquitously Expressed Transcript, a Novel Gene in Infiltrating Ductal Breast
Carcinoma. Poster Presentation. AACR-Advances in Breast Cancer Research, Special
Meeting, Huntington Beach, CA, 2003
Escobar PF, Belinson JL, White A, Shakhova NM, Feldchtein FI, Kareta MV, Gladkova
ND. Diagnostic Efficacy of Optical Coherence Tomography in The Management of PreInvasive and Invasive Cancer of The Uterine Cervix and The Vulva. Presentation:
Eurogin 2003 4/12-16, Paris France.
Escobar PF, Belinson JL. Diagnostic Efficacy of Optical Coherence Tomography in the
Management of Pre-Invasive and Invasive Cancer of the Uterine Cervix and the Vulva.
November/December 2003, Volume 9, Issue 6. The Cancer Journal, The Radium Society.
Escobar PF, Patrick RJ, Crowe JP. Second primary gynecologic neoplasms in patients
with breast carcinoma. Poster Presentation, Society of Gynecologic Oncologist, 35th
annual meeting, San Diego, CA 2004.
Escobar PF, Elder JA, Patrick RJ, Lee KB, Ribicki LA, Crowe JP. Can hormone therapy
use predict the clinical presentation of breast carcinoma. Poster Presentation, Society of
Gynecologic Oncologist, 35th annual meeting, San Diego, CA 2004.
PEER REVIEWED ABSTRACTS – continued
Escobar PF, Bhattacharyya N, Zanotti K, Belinson JL, Banerjee S. Alterations of a
DNA repair pathway gene in early stage ovarian cancer. Poster Presentation, Society of
Gynecologic Oncologist, 35th annual meeting, San Diego, CA 2004.
Feldchtein F, Gladkova N, Shakhova N, Zuccaro G, Shen B, Kareta M, Belinson J,
Escobar PF. Clinical applications of optical coherence tomography: Cleveland Clinic
Studies. Great Lakes Photonics Symposium June 7-11 2004.
Escobar PF, Patrick RJ, Rybicki LA, Crowe JP. Prognostic Significance of Residual
Breast Disease and Axillary Lymph Node Involvement After Primary Induction
Chemotherapy for Locally Advanced Breast Cancer. American Society of Breast
Surgeons, 5th Annual Meeting, Las Vegas, NV 2004.
Saubhik Sengupta, Michael Berk, Rhonda Oates, Escobar PF, Jerome Belinson, Yan Xu.
LPA receptors in ovarian cancer cells as potential therapeutic targets for blocking
metastatic spread. AACR-Annual meeting, 2004.
PF Escobar, R Patrick, Rybicki L, Grundfest-Broniatowski, KIM JA, Crowe JP. Clinical
predictors of residual breast disease after primary induction chemotherapy. Journal of
Clinical Oncology Suppl Vol22,No14S, 49s (Abstract No. 688),July 15,2004.
Escobar PF, Patrick RJ, Rybicki LA, Crowe JP. Prognostic Significance of Residual
Breast Disease and Axillary Lymph Node Involvement After Primary Induction
Chemotherapy for Locally Advanced Breast Cancer. Cleveland Clinic Research Day
2004.
Escobar PF, Patrick RJ, Rybicki LA, Crowe JP. Primary gynecologic neoplasms and
clinical outcomes in patients diagnosed with breast carcinoma. American Society of
Breast Disease, Las Vegas, NV, April 14-16,2005
L. A. Rojas-Espaillat, A. M. Otanes, W. R. Romero, Escobar PF, J. L. Belinson, L. B.
Rojas. Clinical presentation and management of gestational trophoblastic disease: The
experience in developing countries. The 2007 Annual Meeting on Women's Cancer.
P. Roland, M. Stegman, M. Curcio, R. Boothby, E. Grendys, Escobar PF, J. Orr. The
use of chemotherapy and hospice services in patients with ovarian cancer at the end of
life. The 2007 Annual Meeting on Women's Cancer.
Luis Rojas-Espaillat, Escobar PF, Chad Michener, Yaomin Xu, John Barnard, Jerome
Belinson, Peter Rose, Charles Biscotti, Ronald Bukowski, Ram Ganapathi. Molecular
profiling of purified ovarian carcinoma cells from ascites demonstrates a novel resource
for biomarker and prognostic studies. The 2006 Annual Meeting on Women’s Cancer.
PEER REVIEWED ABSTRACTS – continued
Luis Rojas-Espaillat, Andrew Green, Escobar PF, Vernon Cannon, Mehdi Kebria,
Jerome L. Belinson, Peter Rose, Chad Michener. Transmural intestinal involvement with
ovarian, peritoneal or tubal cancer and the potential implications for therapies with
bevacizumab. The 2006 Annual Meeting on Women’s Cancer.
Escobar PF, Patrick RJ, Rybicki LA, Crowe JP. The 2003 staging system for breast
cancer: results of stage migration on survival and future comparisons among stage
groups. Society of Surgical Oncology San Diego, CA, March 23-26, 2006.
Escobar PF, C. Merril, T.M. Menocal, S. Salenius, P.Y.Roland, E. Grendys, J.W.Orr .
Disparities in Genetic Testing: A Descriptive Study of Cancer Genetic Services in a
Community Hospital Comprehensive Cancer Program. European Society of Gynecologic
Oncology, Berlin, Germany – Annual Meeting 2007
Escobar PF, C.A. Mantz, R. Ross, and S. Selinus. Accelerated Partial Breast Irradiation
Using the Mammosite Device: Outcomes for patients treated for pure ductal carcinoma
in situ. European Society of Gynecologic Oncology, Berlin, Germany – Annual Meeting
2007
Mantz C, Brown A, Kokal W, Escobar PF, Kowalsky J, Skowronski C. Favorable Acute
Toxicity Utilizing the SAVI Partial Breast Brachytherapy Device: Initial Results of a
Phase II Trial. 25th Annual Miami Breast Cancer Conference-2008.
Partial Breast Brachytherapy Utilizing the Single-entry, Multicatheter SAVI Device in
Patients with less than 7mm Skin-to-Cavity Distance: Favorable Acute Skin Toxicity
Outcomes from a Phase II Trial. C. Cross, A. Brown, P. Escobar, W. Kokal, C. Mantz.
Astro 2008.
Rasool N, Drake R, Michener C, Escobar P, Rose P, Simpkins F. Phase II pilot Study of
Bevacizumab in combination with Carboplatin and Paclitaxel for treatment of patients
with recurrent/advanced-stage Endometrial Cancer: Interim analysis of safety and
tolerability. Gynecol Oncol 116, March 2010, S2-S169.
Podzielinski I, Quick A, DeSimone C, Chino J, Escobar P, Cohn D, Lopez M, AlvarezSecord A, Havrilesky L, Seamon L. Primary radiation therapy for medically inoperable
patients with clinical stage I and II endometrial cancer. Gynecol Oncol 116, March 2010,
S2-S169.
Liotta M, Drake R, Yang B, Escobar P, Chiesa-Vottero A, Rose P. Vulvar
intraepithelial neoplasia 3 simplex type is a distinct entity associated with invasive
carcinoma of the vulva. Gynecol Oncol 116, March 2010, S2-S169.
PEER REVIEWED ABSTRACTS – continued
Escobar P, Nickles Fader A, Rojas-Espaillat L. Laparoendoscopic single-site riskreducing salpingo-oophorectomy: surgical outcomes and learning curve analysis.
Gynecol Oncol 116, March 2010, S2-S169.
Escobar PF, Nickles Fader A, Rojas-Espaillat L. A multi-institutional experience with
laparoendoscopic single-site surgery in gynecologic oncology. Female Pelvic Medicine &
Reconstructive Surgery, Vol 16, 2 suppl, March/April 2010.
Escobar PF, Starks D, Nickles Fader A, Rojas-Espaillat L. Multi-institutional
experience with single-port laparoscopic hysterectomy with staging for endometrial
cancer. Society of Laparoendoscopic Surgeons, New York, NY, September 2010.
Bedaiwy M, Escobar PF. Laparoendoscopic single-site (LESS) gonadal sparing surgery.
American Society of Reproductive Medicine, Denver, Colorado, October 2010.
Nickles Fader A, Seamon LG, Escobar PF, Frasure HE, Havrilesky LA, Zanotti KM,
Alvarez SA, Rheaume S, Bogges J, Sfakanios G, Cantrell LA, Billow M, Cohn D, Fowler
J, Gehrig PA. Surgical Staging for Type II Endometrial Cancer: Laparotomy or
Minimally Invasive Surgery? Journal of Minimally Invasive Gynecology 17 (2010) S1S24. AAGL Annual Meeting Las Vegas, Nevada Nov 8-12, 2010.
Bedaiwy MA, Starks D, Falcone T, Hurd W, Escobar PF. Laparo-endoscopic single site
(LESS) surgery in patients with benign adnexal disease: A comparative study. Journal
of Minimally Invasive Gynecology 17 (2010) S90-S108. AAGL Annual Meeting Las
Vegas, Nevada, Nov 8-12, 2010.
Starks D, Hood C, Fader AN, Frasure H, Escobar PF. Bilateral salpingo-oophorectomy
by laparoscopic single site surgery (LESS) versus conventional laparoscopy: A
comparison of short term outcomes and immediate costs. Journal of Minimally Invasive
Gynecology 17 (2010) S90-S108. AAGL Annual Meeting Las Vegas, Nevada, Nov 812, 2010.
Uppal S., Frumovitz M, Escobar PF, Ramirez PT. Laparo-endoscopic single site
surgery in gynecology – a review of the literature and available technology. Journal of
Minimally Invasive Gynecology 17 (2010) S178-188. AAGL Annual Meeting Las
Vegas, Nevada, Nov 8-12, 2010.
Liotta M, Escobar PF. Single-port para-aortic lymph node dissection. Gynecol Oncol
120 (2011) S2-S133. doi:10.1016/j.ygyno.2010.12.024. SGO Annual Meeting, Orlando,
Florida, March 2011.
PEER REVIEWED ABSTRACTS – continued
Escobar PF, Frumovitz M, Soliman P, Frasure H, Starks D, Nickles Fader A, Ramirez P.
Comparison of single-port laparoscopy versus standard laparoscopy versus robotic
surgery in patients with endometrial cancer: A multi-institutional study. Gynecol Oncol
120 (2011) S2-S133. doi: 10.1016/j.ygyno.2010.12.039. SGO Annual Meeting, Orlando,
Florida, March 2011.
Bedaiwy MA, Escobar PF. Laparoendoscopic single-site surgery (LESS) in gynecology.
SGS Annual Meeting, San Antonio, Texas, April 2011. Oral and Video Presentation.
BOOK CHAPTERS
Escobar PF, Chiesa-Votero A, Michener CM. Cervical Dysplasia, Sokol & Sokol
Gynecology 2007.
Rose PG, Escobar PF, Biscotti C, Flemming P. Uterine Sarcomas and Unusual
Endometrial Carcinomas. Textbook of Uncommon Cancers Third Edition 2006.
Orr JW, Escobar PF, Roland PY. Cervical Cancer. General Surgery: Principles and
International Practice: Springer (January 2009)
Nickles Fader A, Escobar P, Seamon L, Fowler J. Laparoscopic and Robotic Advances
in Gynecologic Malignancies. Basic Advanced and Robotic Laparoscopy: Elsevier Inc.,
Philadelphia 2010.
Paraiso MFR, Escobar PF. Laparoscopic and robotic-assisted total and supracervical
hysterectomy. Walters MD, Barber MD(eds): Hysterectomy for Benign Disease (with
CD). Elsevier Inc., Philadelphia, 2010.
PEER-REVIEWED PUBLICATIONS
Cohen LS, Escobar PF, Scharm C, Glimco B, Fishman DA. Three-dimensional power
Doppler ultrasound improves the diagnostic accuracy for ovarian cancer prediction.
Gynecol Oncol.2001 Jul;82(1):40-8.
Escobar PF, Markman M, Zanotti K, Webster K, Belinson J. Phase 2 trial of pegylated
liposomal doxorubicin in advanced endometrial cancer. J Cancer Res Clin Oncol. 2003
Nov;129(11):651-4.
Escobar PF, Lurain JR, Singh DK, Bozorgi K, Fishman DA. Treatment of high-risk
gestational trophoblastic neoplasia with etoposide, methotrexate, actinomycin D,
cyclophosphamide, and vincristine chemotherapy. Gynecol Oncol 2003 91; 552-557.
PEER-REVIEWED PUBLICATIONS - continued
Escobar PF, Markman M, Rose P, Zanotti K, Webster K, Belinson JL. Phase 2 Trial of
Carboplatin, Paclitaxel and Irinotecan In Ovarian, Fallopian Tube and Primary Peritoneal
Cancers. Gynecol Oncol. 2004 (92) 192-196.
Sandruck J, Escobar PF, Lurain JR, Fishman DA. Uterine leiomyosarcoma metastatic to
the sphenoid sinus: a case report and review of the literature. Gynecol Oncol. 2004 (92)
701-704.
Escobar PF, Belinson JL, White A, Shakhova NM, Feldchtein FI, Kareta MV, Gladkova
ND. Diagnostic Efficacy of Optical Coherence Tomography in The Management of PreInvasive and Invasive Cancer of The Uterine Cervix and The Vulva. Int J Gynecol
Cancer 2004, 14, 470-474.
Sokol AI, Paraiso MFR, Cogan SL, Bedaiwy MA, Escobar PF, Barber MD. Prevention
of vesicovaginal fistulas after laparoscopic hysterectomy with electrosurgical cystotomy
in female mongrel dogs. Am J Obst Gynecol March 2004 • Volume 190 • Number 3.
Wang L, Bhattacharyya N, Chelsea DM, Escobar PF, Banerjee S. A novel nuclear
protein, MGC5306 interacts with DNA polymerase beta and has a potential role in
cellular phenotype. Cancer Res. 2004 Nov 1;64(21):7673-7.
Escobar PF, Baynes D, Crowe JP. Ductoscopy-assisted microdochectomy. Int J Fertil
Womens Med. 2004 Sep-Oct;49(5):222-4.
Escobar PF, VonGruenigen V. First case of a centropelvic recurrence after radical
trachelectomy: literature review and implications for the preoperative selection of
patients. Commentary. Women's Oncology Review 4 (3), pp. 209-210
Kefah Mokbel, Escobar PF and Tadaharu Matsunaga. Mammary ductoscopy: current
status and future prospects. Eur J Surg Oncol. 2005 Feb;31(1):3-8.
Escobar PF, Rojas-Espalliat L, Belinson JL. Optical diagnosis of cervical dysplasia. A
promising strategy in low-resource settings. Int. J Gynecology and Obstetrics 2005
Apr;89(1):63-4.
Green A, Escobar PF. Michener CM, VonGruenigen V. The Martius Flap Neovagina
Revisited. Int. J Gynecol Cancer 2005, 15,964-966.
Escobar PF, Michener CM, Rose PG. Second-look Operation Improves Survival in
Suboptimal Debulked Stage III Ovarian Cancer. (Letter) Int J Gynecol Cancer. 2005
Nov-Dec;15(6):1258; author reply 1259.
Green AE, Escobar PF, Stellato T, Hallowell P, von Gruenigen VE. Bariatric Surgery in
the field of gynecologic oncology. Int J Gynecol Cancer. 2005 Nov-Dec;15(6):1254-7.
PEER-REVIEWED PUBLICATIONS - continued
Escobar PF, Rose P. Taxotere in Ovarian Cancer. Expert Opin Pharmacother. 2005
Dec;6(15):2719-26.
Escobar PF, Patrick RJ, Sebek B, Procop G, Rice J, Crowe JP. Schistosomiasis
presenting with microcalcifications on mammography. Breast J. 2005 NovDec;11(6):489-90.
Noriega-Rangel J, Escobar PF. Anatomical and Surgical Considerations for Minimally
Invasive Surgery of Adnexal Mass Lesions. MedUNAB Vol 8 No.8 Agosto 2005.
Sarakbi WA, Escobar PF, Mokbel K.The potential role of breast ductoscopy in breast
cancer screening. Int J Fertil Womens Med. 2005 Sep-Oct;50(5 Pt 1):208-11.
Escobar PF, Keith L, Reeves J. Long-term follow-up of isolated pathologic and
physiologic abnormalities preceding breast cancer. Int J Fertil Womens Med Nov-Dec;
50 -2005
Escobar PF, Crowe JP, Matsunaga T, Mokbel K. Clinical Applications of Mammary
Ductoscopy. American Journal of Surgery.191 (2006) 211–215.
Al Sarakbi W, Worku D, Escobar PF, Mokbel K. Breast papillomas: current
management with a focus on a new diagnostic and therapeutic modality. Int Semin Surg
Oncol. 2006 Jan 17;3(1):1
Escobar PF, Patrick R, Rybicki L, Al-Husaini N, Michener CM, Crowe JP. Primary
Gynecologic Neoplasms and Clinical Outcomes in Patients Diagnosed with Breast
Carcinoma. Int J Gynecol Cancer 2006, 16 (Suppl. 1), 118–122
Escobar PF, Patrick RJ, Rybicki LA,Grundfest-Broniatowski SF, Kim JA, Crowe JP.
Prognostic Significance of Residual Breast Disease and Axillary Lymph Node
Involvement in Patients with Locally Advanced Breast Cancer. Annals of Surgical
Oncology 2006 Jun;13(6):783-7. Epub 2006 Apr 12.
Crowe JP, Patrick RJ, Rybicki LA, Escobar PF, Weng DE, Budd GT, Tubbs RR, Procop
GW, Hicks DG. A Data Model to Predict HER2 Status in Breast Cancer Based on the
Clinical and Pathologic Profiles of A Large Patient Population at a Single Institution.
The Breast 2006 May 19.
Escobar PF, Patrick RJ, Sebek B, Procop G, Rice J, Crowe JP. Multiple Myeloma of the
Breast. Breast J. 2006 Jul-Aug;12(4):387-8.
PEER-REVIEWED PUBLICATIONS - continued
Escobar PF, L. Rojas-Espaillat, S. Tisci, C. Enerson, J. Brainard, J. Smith, N. J.Tresser,
F.I. Feldchtein, L.B. Rojas, J.L.Belinson. Optical Coherence Tomography as a Diagnostic
Aid to Visual Inspection and Colposcopy for Pre-Invasive and Invasive Cancer of the
Uterine Cervix. Int J Gynecol Cancer. 2006 Sep-Oct;16(5):1815-22.
Kim KS, Sengupta S, Berk M, Kwak YG, Escobar PF, Belinson J, Mok S, Xu Y.
Hypoxia Enhances Lysophosphatidic Acid Responsiveness in Ovarian Cancer Cells and
Lysophosphatidic Acid Induces Ovarian Tumor Metastasis In vivo.Cancer Res. 2006 Aug
15;66(16):7983-90.
Kim KS, Sengupta S, Berk M, Kwak YG, Escobar P, Belinson J, Mok S, Xu Y.
Lysophosphatidic acid down regulates tissue inhibitor of metalloproteinase’s, which are
negatively involved in lysophosphatidic acid-induced cell invasion. Oncogene. 2006 Nov
27
Escobar PF, Breast duct micro-endoscopy. (Letter) Breast. 2006 Dec;15(6):704. Epub
2006 Aug 9.
Crowe JP, Patrick RJ, Rybicki LA, Budd GT, Escobar PF, Tubbs RR, Hicks DG. HER2
status in bilateral breast cancer. Int J Fertil Womens Med. 2006 Sep-Oct;51(5):219-23.
McBee WC, Escobar PF, Falcone T. Which ovarian masses need intervention? Cleve
Clin J Med. 2007 Feb;74(2):149-57.
Escobar PF, Patrick RJ, Rybicki LA, Weng DE, Crowe JP.The 2003 revised TNM
Staging system for breast cancer:Results of Stage re-classification on survival and future
comparisons among stage groups. Ann Surg Oncol. 2007 Jan;14(1):143-7. Epub 2006
Oct 22.
McBee WC, Emery SP, Escobar PF. Heterotopic pregnancy presenting at 18 weeks
gestational age. J. Repro. Med 2007 Aug; 52(8).
Escobar PF. Case study. Metastasis to the breast from extramammary sites. Breast
Cancer Reviews, Issue No 16, Summer 2007, ISSN 1747-8138.
Escobar PF, Howard JL, Kelly J ,Roland PY, Grendys E, Dosoretz D , Orr JW.
Uretero-Arterial Fistulas after Radical Pelvic Surgery: Pathogenesis, Diagnosis and
Therapeutic Modalities. Int J Gynecol Cancer 2007 Vol 6.
Escobar PF,Orr JW, Roland PY, Grendys EC. Ovarian cancer at young age: the
contribution of mismatch-repair defects in a population-based series of epithelial ovarian
cancer before age 40 (Letter). Int J Gynecol Cancer 2007 Vol 6.
PEER-REVIEWED PUBLICATIONS - continued
Orr JW, Naumann W, Escobar PF, "Attitude is a little thing that makes a big difference"
Winston Churchill. Gynecol Oncol. 2008 Apr;109(1):147-51; author reply 151-3.
Sengupta S, Michener CM, Escobar PF, Belinson J, Ganapathi R.Ovarian Cancer
Immuno-reactive Antigen domain containing 1 (OCIAD1), a key player in ovarian cancer
cell adhesion. Gynecol Oncol. 2008 Mar 5.
Orr J Jr, Kelley J 3rd, Dizon D, Escobar P, Fleming E, Gemignani M, Hetzel D, Hoskins
W, Kieback D, Kilgore L, LaPolla J, Lewin S, Lucci J, Markman M, Pothuri B, Powell
CB, Tejada-Berges T. Society of gynecologic oncologists position paper: breast cancer
care. Gynecol Oncol. 2008 Jul;110(1):7-12.
Escobar PF, ORR JW. HPV Vaccine. The Female Patient 2008, Vol. 33, No.11:18-22
Escobar PF, Nickles Fader A, Paraiso MP, Kaouk JH, Falcone T. Robotic Assisted
Laparo-Endoscopic Single Site Surgery in Gynecology: Initial Report and Technique. J
Minim Invasive Gynecol. 2009 Sept-Oct; 16(5): 589-91.
Nickles Fader A, Escobar PF. Laparoendoscopic Single-Site Surgery (LESS) in
Gynecologic Oncology: Technique and Initial Report. Gynecol Oncol. 2009 Aug;
114(2): 157-61.
Escobar PF. Office Hysteroscopy in HNPCC Patients. Int J Gynecol Cancer. 2009
Aug; 19(6):1152.
Liotta M, Rose PG, Escobar PF. Pulmonary hypertension in two patients treated with
bevacizumab for recurrent ovarian cancer. Gynecol Oncol. 2009 Nov; 115(2):308-9
Escobar PF, Nickles Fader A. Promising minimal surgical approach for gynecologic
disease. Doi:10.1016/j.ygyno. 2009.07.018.
Nickles Fader A, Ueda SM, Escobar PF. New Minimally Invasive Treatment Options in
Gynecologic Oncology. US Obstet and Gyn (In Press).
Escobar PF, Bedaiwy M, Nickles Fader A, Falcone T. Laparo-Endoscopic Single Site
(LESS) Surgery in Patients with Benign Adnexal Disease. Fertil Steril. 2010 Apr;
93(6):2074.e7-2074.e10. Epub 2010 Jan 25.
Escobar PF, Nickles Fader A, Rojas-Espaillat L. A Multi-Institutional Experience with
Laparoendoscopic Single-Site Surgery in Gynecologic Oncology. Oral poster
presentation. SGS 36th Annual Scientific Meeting, Tucson, Arizona, April 12, 2010.
Escobar PF. Laparoendoscopic single-site (LESS) lymphadenectomy in Gynecologic
Oncology: Technique and Instrumentation (Accepted Int J Gynecol Cancer 2010).
PEER-REVIEWED PUBLICATIONS - continued
Escobar PF, Starks DC, Nickles Fader A, Barber M, Rojas-Espaillat L. Single-Port Risk
Reducing Salpingo-Oophorectomy with and without Hysterectomy: Surgical Outcomes
and Learning Curve Analysis. Gynecol Oncol. 2010 Oct;119(1):43-7.
Escobar PF, Nickles Fader A, Rasool N, Rojas-Espaillat L. Single-Port Laparoscopic
Pelvic and Para-Aortic Lymphadenectomy: Development of a Technique and
Instrumentation. Int J Gynecol Cancer 2010 Oct;20(7): 1268-73.
Nickles Fader A, Cohen S, Escobar PF, Gunderson C. Laparoendoscopic Single-Site
Surgery (LESS) in Gynecology. Curr Opin Obstet and Gyn 2010 Aug;22(4): 331-8.
Escobar PF, Starks D, Nickles Fader A, Catenacci M, Falcone T. Single Port and
Natural Orifice Surgery in Gynecology. Fertil Steril 2010 Dec;94(7): 2497-502.
Escobar PF, Kaouk JH, Geisler D, Kroh M, Nickles Fader A, Falcone T. Single-Port
Laparoscopy, NOTES, and Endoluminal Surgery. Diagnostic and Therapeutic
Endoscopy, Vol 2010, Article ID 710130, 2 pages, 2010. doi:10.1155/2010/710130
Fader AN, Rojas-Espaillat L, Okechukwu I, Grumbine F, Escobar P. Laparoendoscopic
Single-Site Surgery (LESS) in Gynecology: A multi-institutional evaluation. Am J
Obstet Gynecol. 2010 Nov;203(5):501.e1-6.
Escobar PF, Haber GP, Kaouk J, Kroh M, Chalikonda S, Falcone T. Single-Port
Surgery: Laboratory Experience with the da Vinci “VESPA” Platform”. (Accepted JSLS
2010)
Bedaiwy MA, Escobar PF. Laparoendoscopic Single Site (LESS) Gonadal Sparing
Surgery. Fertil Steril Vol 94, No 4, Supplement, September 2010.
Haber GP, White M, Autorino R, Escobar P, Kroh M, Chalikonda S, Khanna R, Forest
S, Yang B, Altunrende F, Stein R, Kaouk J. Novel Robotic da Vinci Instruments for
Laparoendoscopic Single-Site Surgery. Urology 2010 Dec;76(6): 1279-82.
Escobar PF, Kebria M, Falcone T. Evaluation of a novel single-port robotic platform in
the cadaver model for the performance of various procedures in gynecologic oncology.
Gynecol Oncol. 2011 Mar;120(3):380-4. doi: 10.1016/j.ygyno.2010.11.005
Nickles Fader A, Levinson K, Gunderson C, Winder A, Escobar PF. Laparoendoscopic
Single-Site Surgery in Gynecology: A New Frontier in Minimally Invasive Surgery. J
Minim Access Surg. 2011 Jan;7(1):71-7.
PEER-REVIEWED PUBLICATIONS - continued
Bedaiwy MA, Escobar PE, Pinkerton J, Hurd W. Laparoendoscopic single-site
salpingectomy in isthmic and ampullary ectopic pregnancy: preliminary report and
technique. J Minim Invasive Gynecol, 2011 Mar-Apr; 18(2):230-3. doi:
10.1016/j.jmig.2010.12.004
Liotta M, Escobar PF. Hormone replacement after breast cancer: is it safe? Clin Obstet
Gynecol 2011 Mar;54(1):173-9.
Frumovitz M, Escobar P, Ramirez PT. Minimally invasive surgical approaches for
patients with endometrial cancer. Clin Obstet Gynecol. 2011 Jun;54(2):226-34.
REFERENCES
Jerome L. Belinson, M.D.
The Cleveland Clinic
Fellowship Director Gynecologic Oncology
Joseph P. Crowe, M.D.
The Cleveland Clinic
Director Breast Center, Chief Breast Surgeon
Peter Rose, M.D.
The Cleveland Clinic
Chief, Section of Gynecologic Oncology
John R. Lurain, M.D.
Northwestern University
Fellowship Director, Gynecologic Oncology
4/11